Online inquiry

IVTScrip™ mRNA-Human ARHGAP10, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK28581MR)

This product GTTS-WK28581MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ARHGAP10 protein. This product can be used in FGFR1 High NME5- epithelial cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_024605.4
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 79658
UniProt ID A1A4S6
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARHGAP10, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK28581MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK8959MR IVTScrip™ mRNA-Human ADORA2A, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ADORA2A
GTTS-WK13774MR IVTScrip™ mRNA-Human ADTRP, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA ADTRP
GTTS-WK5199MR IVTScrip™ mRNA-Human CD59, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA CD59
GTTS-WK2348MR IVTScrip™ mRNA-Human CD71, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA CD71
GTTS-WK23324MR IVTScrip™ mRNA-Human ASPM, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ASPM
GTTS-WK25955MR IVTScrip™ mRNA-Human ARMC4, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ARMC4
GTTS-WK1519MR IVTScrip™ mRNA-Human RUNX2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA RUNX2
GTTS-WK18436MR IVTScrip™ mRNA-Human alpha-Sarcoglycan, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA alpha-Sarcoglycan
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW